Gergely Szakács

Identifying new topoisomerase II poison scaffolds by combining publicly available toxicity data and 2D/3D-based virtual screening

Csaba Magyar, Anna Lovrics, Veronika F. S. Pape, 2019, Journal of Cheminformatics.

Hot topics, recent advances and novel approaches for clinical intervention

Gergely Szakács, Heidrun Potschka, Irwin M. Arias, 2011 .

Data-Driven Ensemble Docking to Map Molecular Interactions of Steroid Analogs with Hepatic Organic Anion Transporting Polypeptides

Barbara Zdrazil, Gergely Szakács, Alzbeta Türková, 2021, J. Chem. Inf. Model..

Expression pattern of the human ABC transporters in pluripotent embryonic stem cells and in their derivatives

György Várady, Balázs Sarkadi, Gergely Szakács, 2014, Cytometry. Part B, Clinical cytometry.

Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.

John N Weinstein, Mark Reimers, Gergely Szakács, 2004, Cancer cell.

Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer

Gergely Szakács, Tímea Imre, G. Szakács, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Ins and outs of the ABCG2 multidrug transporter: an update on in vitro functional assays.

Balázs Sarkadi, Gergely Szakács, László Homolya, 2009, Advanced drug delivery reviews.

The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox).

Balázs Sarkadi, András Váradi, Gergely Szakács, 2008, Drug discovery today.

Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells.

Gergely Szakács, Noeris K Salam, Noeris K. Salam, 2009, Journal of medicinal chemistry.

Analysis of ATP-Binding Cassette Transporter Expression in Drug-Selected Cell Lines by a Microarray Dedicated to Multidrug Resistances⃞

John N Weinstein, Yves Pommier, Gergely Szakács, 2004, Molecular Pharmacology.